Immunotherapy Use Prior to Liver Transplant in Patients with Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer-related mortality worldwide, and its incidence has increased rapidly in the United States over the past two decades. Liver transplant is considered curative, but is not always possible, and pre-transplant immunotherapy is of great...

Descripción completa

Detalles Bibliográficos
Autores principales: Woo, Stephanie M., Kimchy, Alexandra V., Sequeira, Lynette M., Dorris, Charles S., He, Aiwu R., Rangnekar, Amol S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777129/
https://www.ncbi.nlm.nih.gov/pubmed/36547185
http://dx.doi.org/10.3390/curroncol29120771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777129/
https://www.ncbi.nlm.nih.gov/pubmed/36547185
http://dx.doi.org/10.3390/curroncol29120771

Ejemplares similares